Evidence map›Paper›PMID 27871728›Full record

ReviewTrends in neurosciences2016

The CHRNA5-A3-B4 Gene Cluster and Smoking: From Discovery to Therapeutics.

Glenda Lassi, Amy E Taylor, Nicholas J Timpson, Paul J Kenny, Robert J Mather, Tim Eisen, Marcus R Munafò

Abstract readReview
In one paragraph

Review in Trends in neurosciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Mendelian Randomization Analysis of the Causal Effect of Cigarette Smoking on Hospital Costs.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Glenda LassiUK Centre for Tobacco and Alcohol Studies, School of Experimental Psychology, University of Bristol, Bristol, UK; Oncology Translational Medicine Unit, Early Clinical Development, AstraZeneca, Cambridge, UK. Electronic address: glenda.lassi@bristol.ac.uk.
Amy E TaylorUK Centre for Tobacco and Alcohol Studies, School of Experimental Psychology, University of Bristol, Bristol, UK; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Nicholas J TimpsonMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Paul J KennyDepartment of Neuroscience and Experimental Therapeutics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Robert J MatherNeuroscience iMED, AstraZeneca, Cambridge, MA, USA.
Tim EisenOncology Translational Medicine Unit, Early Clinical Development, AstraZeneca, Cambridge, UK; Department of Oncology, University of Cambridge, Cambridge, UK.
Marcus R MunafòUK Centre for Tobacco and Alcohol Studies, School of Experimental Psychology, University of Bristol, Bristol, UK; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
Development of a5* nAChR positive allosteric modulators for tobacco dependenceR01DA030929 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI KENNY, PAUL J., LINDSTROM, JON MARTIN · 2011 to 2015
$7.1M
British Heart FoundationCancer Research UKMedical Research Council MC_UU_12013/3Medical Research Council MC_UU_12013/6Medical Research Council MR/K023195/1NCATS NIH HHS UL1 TR001425NIDA NIH HHS R01 DA030929
6 · The paper itself

Abstract

Genome-wide association studies (GWASs) have identified associations between the CHRNA5-CHRNA3-CHRNB4 gene cluster and smoking heaviness and nicotine dependence. Studies in rodents have described the anatomical localisation and function of the nicotinic acetylcholine receptors (nAChRs) formed by the subunits encoded by this gene cluster. Further investigations that complemented these studies highlighted the variability of individuals' smoking behaviours and their ability to adjust nicotine intake. GWASs of smoking-related health outcomes have also identified this signal in the CHRNA5-CHRNA3-CHRNB4 gene cluster. This insight underpins approaches to strengthen causal inference in observational data. Combining genetic and mechanistic studies of nicotine dependence and smoking heaviness may reveal novel targets for medication development. Validated targets can inform genetic therapeutic interventions for smoking cessation and tobacco-related diseases.

Indexed as

AnimalsHumansMultigene FamilyReceptors, NicotinicSmokingReceptors, NicotinicCHRNA5–A3–B4phenotype definitionprecision medicinesmoking behaviourtobacco-related disorders

Identifiers

PMID27871728
PMCPMC5152594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.